Report description
This report represents the global and regional analysis of Apixaban in terms of Dosage, Strength, API, application Wise segmentation, market size & market growth (in terms of value & volume) trends including forecasting upto 5 years. All the region wise segmentation of buyer supplier is described properly. The report focuses on the top continent Wise (North America, Europe, Japan, China and other regions (India, Southeast Asia, Central & South America, and Middle East & Africa) manufacturer & buyers also.
Apixaban Introduction
“Apixaban” is White to pale yellow powder which is soluble in water, act as an oral anticoagulant drug used in the treatment of thromboembolic diseases, developed by Pfizer & Bristol Mayer Squibb. It is marketed by the name of eliquis, available in the form of tablet with varying strength. In case of post-orthopedic surgical procedures it is used to lower the risk of developing venous thrombosis. Apixaban mechanism act by inhibiting coagulation which prevents development of blood clot. If administered orally, the half-life is 12 hours (due to prolonged absorption). If administered by I.V., the half-life is about 5 hours
Report highlights
- Provide manufacturing capacity, consumption, current & past status & also the forecasting upto 2022.
- Provide complete overview including type, application & forecast region.
- Provide complete analysis of API & formulation including brand names, strength & market overview.
- Provide focused analysis of key manufacturer with their production volume, market share & also help to identify market competition landscape with SWOT analysis.
- Historical, current and projected market size in terms of volume and value.
- Analyze the global & regional potential market, advantages, risk & opportunity.
- Identify significant trends and factors driving or inhibiting the market growth.
- In-depth coverage of complete market in terms of supplier, buyer, price, trend, growth & forecasting.
The report covers exhaustive analysis on
- Market Segments
- Market Dynamics
- Brands In Market
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved
- Forecasting
- Technology
The report includes Regional analysis on
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Rest of Latin America)
- Europe (Germany, Italy, France, U.K, Spain & Rest of Europe)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Middle East and Africa (GCC Countries, South Africa, North Africa & Rest of MEA)
Top Players in Apixaban industry
- Bristol-Myers Squibb
- Pfizer
- Polpharma
- Centaur Pharmaceutical
- Beijing Cooperate Pharmaceutical
- Boehringer Ingelheim
- Abbott India Ltd
- Teva Pharmaceutical Industries Ltd
- Bayer Healthcare AG
- Mitsubishi Tanabe Pharma Co
Key Questions answered by report
- What was the market size trend of 2014-2016?
- What will be the market size trend of next 4-5 years?
- What are the most common brands in terms of volume?
- How much brands available for Apixaban?
- Whare the key players of Apixaban API?
- What are the major application industries & emerging industries?
- Whare the key vendors present in the market?
- How the future opportunities & market drivers will affect the market dynamics & ongoing trends?
- Which one segment from global coverage will be lucrative & will grow?
- What are the main market opportunities and threats faced by the vendors?
- What are the strategies are following by the existing market players?
CHAPTER 1 RESEARCH METHODOLOGY
CHAPTER 2 REPORT DESCRIPTION
CHAPTER 3 APIXABAN EXECUTIVE SUMMARY
CHAPTER 4 APIXABAN BASIC HIGHLIGHTS
- 4.1. Product Overview
- 4.2. CAS No & Molecular Weight
- 4.3. Innovator Details
- 4.4. Priority & Patent Expiry
- 4.5. Molecular Formula
- 4.6. Market Status
CHAPTER 5 GLOBAL APIXABAN PHYSICAL FORMS, GRADES & APPLICATION INDUSTRY
- 5.1. Apixaban Forms (Anhydrous or Monohydrate)
- 5.2. Apixaban Grades Description
- 5.3. Apixaban Route of Administration
- 5.4. Apixaban Synonym
- 5.5. Apixaban Applications
CHAPTER 6 APIXABAN MANUFACTURING PROCESS WITH UPSTREAM & DOWNSTREAM
- 6.1. Apixaban Manufacturing Process Routes & Flow Chart
- 6.2. Apixaban Upstream & Downstream Products
CHAPTER 7 APIXABAN BRAND LIST & MECHANISM OF ACTION
- 7.1. Apixaban All Global Brands
- 7.2. Apixaban Dosage & Their Strengths
- 7.3. Apixaban Mechanism of Action
CHAPTER 8 APIXABAN (FORMULATION) REGION WISE MARKET OVERVIEW
- 8.1. Apixaban Market Overview In Asia-Pacific (China, India, South Korea & Rest of Asia Pacific Available)
- 8.2. Apixaban Market Overview In Europe (Germany, Russia, United Kingdom & Rest of Europe Available)
- 8.3. Apixaban Market Overview In North America (Canada, US & Rest of North America Available)
- 8.4. Apixaban Market Overview In South America (Brazil, Argentina & Rest of South America Available)
- 8.5. Apixaban Market Overview In Middle East & Africa (GCC Countries, South Africa, North Africa & Rest of MEA Available)
CHAPTER 9 APIXABAN (API) REGION WISE MARKET OVERVIEW
- 9.1. Apixaban Market Overview In Asia-Pacific (China, India, South Korea & Rest of Asia Pacific Available)
- 9.2. Apixaban Market Overview In Europe (Germany, Russia, United Kingdom & Rest of Europe Available)
- 9.3. Apixaban Market Overview In North America (Canada, US & Rest of North America Available)
- 9.4. Apixaban Market Overview In South America (Brazil, Argentina & Rest of South America Available)
- 9.5. Apixaban Market Overview In Middle East & Africa (GCC Countries, South Africa, North Africa & Rest of MEA Available)
CHAPTER 10 APIXABAN (API & FORMULATION) CONTINENT & COUNTRY WISE MANUFACTURERS, MANUFACTURING VOLUME & CONTACT OVERVIEW
- 10.1. Apixaban Continent Wise Manufacturers
- 10.2. Apixaban Continent Wise Manufacturing Volume
- 10.3. Apixaban Country Wise Manufacturers
- 10.4. Apixaban Country Wise Manufacturing Volume
- 10.5. Apixaban Manufacturers Contact Overview
CHAPTER 11 APIXABAN GLOBAL PRICE TREND ANALYSIS OF LAST 3 YEARS
- 11.1. Apixaban Global Price Trend Analysis
- 11.2. Apixaban Country Wise Price Trend Analysis
CHAPTER 12 APIXABAN INTERNATIONAL MARKET OVERVIEW
- 12.1. Global Demand/ Supply & Global Prices
- 12.2. Major Destinations Involved In Trade
- 12.3. Major Manufacturers (Capacities & Prices)
CHAPTER 13 APIXABAN (FORMULATION) GLOBAL MARKET SIZE & MARKET GROWTH FORECASTING (2017-2022) ANALYSIS
- 13.1. Apixaban Global Market Size (Past & Future Forecasting)
- 13.2. Apixaban Global Market Growth (Past & Future Forecasting)
- 13.3. Apixaban Continent Wise Market Size (Past & Future Forecasting)
- 13.4. Apixaban Continent Wise Market Growth (Past & Future Forecasting)
CHAPTER 14 APIXABAN (FORMULATION) CUSTOMER WISE CONSUMPTION, QUANTITY & CONTACT OVERVIEW
- 14.1. Apixaban Global Consumers
- 14.2. Apixaban Global Consumers As Per Consumption Quantity
- 14.3. Apixaban Continent Wise Consumer
- 14.4. Apixaban Continent Wise Consumer As Per Consumption Quantity
- 14.5. Apixaban Country Wise Consumer
- 14.6. Apixaban Country Wise Consumer As Per Consumption Quantity
- 14.7. Apixaban Consumers Contact Overview
CHAPTER 15 APIXABAN CONTINENT WISE EXPORT/ IMPORT ANALYSIS
- 15.1. Apixaban Continent Wise Import Analysis
- 15.2. Apixaban Continent Wise Export Analysis
- 15.3. Apixaban Country Wise Import Analysis
- 15.4. Apixaban Country Wise Export Analysis
CHAPTER 16 APIXABAN WORLDWIDE SWOT ANALYSIS
- 16.1. Apixaban Strength Analysis
- 16.2. Apixaban Weakness Analysis
- 16.3. Apixaban Opportunity Analysis
- 16.4. Apixaban Threat Analysis
CHAPTER 17 APIXABAN REPORT BASED BUSINESS RECOMMENDATION
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
